TY - JOUR
T1 - Serial sampling of high-sensitivity cardiac troponin T may not be required for prediction of acute myocardial infarction diagnosis in chest pain patients with highly abnormal concentrations at presentation
AU - Mueller-Hennessen, Matthias
AU - Mueller, Christian
AU - Giannitsis, Evangelos
AU - Biener, Moritz
AU - Vafaie, Mehrshad
AU - DeFilippi, Christopher R.
AU - Christ, Michael
AU - Ordonez-Llanos, Jorge
AU - Panteghini, Mauro
AU - Plebani, Mario
AU - Verschuren, Franck
AU - Melki, Dina
AU - French, John K.
AU - Christenson, Robert H.
AU - Body, Richard
AU - McCord, James
AU - Dinkel, Carina
AU - Katus, Hugo A.
AU - Lindahl, Bertil
PY - 2017
Y1 - 2017
N2 - BACKGROUND: Guidelines for diagnosing acute myocardial infarction (AMI) recommend adding kinetic changes to the initial cardiac troponin (cTn) blood concentration to improve AMI diagnosis. We hypothesized that kinetic changes may not be required in patients presenting with highly abnormal cTn. METHODS: Patients presenting with suspected AMI to the emergency department were enrolled in a prospective diagnostic study. We assessed the positive predictive value (PPV) of initial high-sensitivity cardiac troponin T (hs-cTnT) blood concentrations alone and in combination with kinetic changes for AMI. Predefined relative changes (δ change of ≥20%) and absolute changes (δ change ≥9.2 ng/L) within different time intervals (1 h, 2 h, and 4 -14 h after presentation) were assessed. The final diagnosis was adjudicated by 2 independent cardiologists. RESULTS: Among 1282 patients, 213 (16.6%) patients had a final diagnosis of AMI. For AMI prediction, PPVs increased from 48.8% for an initial hs-cTnT <14 ng/L to 87.2% for <60 ng/L, whereas PPVs remained unchanged for higher hs-cTnT concentrations at baseline (87.1% for both <80 ng/L and <100 ng/L). With addition of 20% relative δ change, PPVs were not further improved in patients with baseline hs-cTnT <80 ng/L using the 1-h (84.0%) and 2-h (88.9%) intervals, and only minimally when extending the interval to 4-14 h (91.2% for<80 ng/L and 90.4% for<100 ng/L, respectively). Similar findings were observed when applying absolute changes. CONCLUSIONS: In chest pain patients with highly abnormal hs-cTnT concentrations at presentation, subsequent blood draws may not be required, as they do not provide incremental diagnostic value for prediction of AMI diagnosis.
AB - BACKGROUND: Guidelines for diagnosing acute myocardial infarction (AMI) recommend adding kinetic changes to the initial cardiac troponin (cTn) blood concentration to improve AMI diagnosis. We hypothesized that kinetic changes may not be required in patients presenting with highly abnormal cTn. METHODS: Patients presenting with suspected AMI to the emergency department were enrolled in a prospective diagnostic study. We assessed the positive predictive value (PPV) of initial high-sensitivity cardiac troponin T (hs-cTnT) blood concentrations alone and in combination with kinetic changes for AMI. Predefined relative changes (δ change of ≥20%) and absolute changes (δ change ≥9.2 ng/L) within different time intervals (1 h, 2 h, and 4 -14 h after presentation) were assessed. The final diagnosis was adjudicated by 2 independent cardiologists. RESULTS: Among 1282 patients, 213 (16.6%) patients had a final diagnosis of AMI. For AMI prediction, PPVs increased from 48.8% for an initial hs-cTnT <14 ng/L to 87.2% for <60 ng/L, whereas PPVs remained unchanged for higher hs-cTnT concentrations at baseline (87.1% for both <80 ng/L and <100 ng/L). With addition of 20% relative δ change, PPVs were not further improved in patients with baseline hs-cTnT <80 ng/L using the 1-h (84.0%) and 2-h (88.9%) intervals, and only minimally when extending the interval to 4-14 h (91.2% for<80 ng/L and 90.4% for<100 ng/L, respectively). Similar findings were observed when applying absolute changes. CONCLUSIONS: In chest pain patients with highly abnormal hs-cTnT concentrations at presentation, subsequent blood draws may not be required, as they do not provide incremental diagnostic value for prediction of AMI diagnosis.
UR - https://hdl.handle.net/1959.7/uws:63968
U2 - 10.1373/clinchem.2016.258392
DO - 10.1373/clinchem.2016.258392
M3 - Article
SN - 0009-9147
VL - 63
SP - 542
EP - 551
JO - Clinical Chemistry (Washington , DC)
JF - Clinical Chemistry (Washington , DC)
IS - 2
ER -